Latest news and video coverage curated from trusted media outlets
WHO: 4 Indian cough syrups being probed after 66 children die in Gambia|Oneindia news *International
Credit: Oneindia Duration: 02:22Published
You Might Like
Gambia cough syrup deaths: Govt panel says info shared by WHO so far inadequate to determine aetiologyRutendo Kuwana from the WHO on October 13 had written to the DCGI seeking to know the progress with the investigation of the manufacturer of the four cough syrups -- the Sonipat-based Maiden..
Gambia Children Death Case: India-made cough syrup allegedly kills 66 children in Africa - all you need to knowGambia child death case: The World Health Organisation has issued alerts of India-made Maiden Pharmaceuticals Limited cough syrup "potentially linked with acute kidney injuries and 66 children`s..
Govt forms panel to probe WHO report on kids' deaths in GambiaThe Centre on Wednesday formed a four-member committee to examine details and 'adverse event' reports received from the WHO on the deaths of 66 children in Gambia that are being linked potentially to..
Centre forms four-member expert team to probe WHO claims on Maiden PharmaceuticalsLHI: The Central Government on Wednesday formed a four-member expert committee to investigate the report sent by the World Health Organisation (WHO) on the deaths of 66 children in Gambia by..
Haryana minister Anil Vij says Maiden Pharmaceuticals asked to shut production of cough syrups after WHO alertHealth Minister Anil Vij said the samples of the three syrups have been sent for chemical analysis at the Central Drug Laboratory in Kolkata.
Maiden Pharma may lose import-export licence over cough syrup controversy in GambiaThe suspension of membership implies that Maiden Pharmaceuticals will not be eligible to receive any incentives.
Maiden Pharma under scrutiny after 66 children died consuming cough syrup in GambiaThe drug regulators have obtained samples of cold and cough medicine from Maiden Pharmaceuticals in response to a WHO medical alert.
Firm behind Gambia child deaths a repeat offender in IndiaThe Central Drug Standard Control Organisation (CDSCO) has been quick to assure people that the cough syrup which killed 66 children in Gambia was not being sold locally in India, but the same company,..
Centre monitoring, taking updates from state regulatory agencies about Maiden Pharmaceuticals Ltd, its products
DO NOT use them: WHO issues alert on four cough syrups made by India's Maiden Pharmaceuticals
Also reported by •Zee News •IndiaTimes
With raids and show-cause notice, govt plans mega crackdown on cough syrup maker under WHO lens over Gambia deathsThe WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.
Gambia children deaths: What is Maiden Pharmaceuticals Limited and who owns the company? What are WHO's allegations?India's drug regulator, meanwhile, has launched a probe into WHO's allegations.
WHO alert on 4 Indian cough syrups as 66 Gambian kids dieThe WHO on Wednesday issued a medical product alert on four ‘cough & cold’ syrups made by an Indian pharmaceutical firm — Maiden Pharmaceuticals Ltd, Sonipat, Haryana — warning they could be..